40 related articles for article (PubMed ID: 6089134)
1. Central Control of Feeding Behavior by the Secretin, PACAP, and Glucagon Family of Peptides.
Sekar R; Wang L; Chow BK
Front Endocrinol (Lausanne); 2017; 8():18. PubMed ID: 28223965
[TBL] [Abstract][Full Text] [Related]
2. Modulation of human neutrophil apoptosis by gut hormones.
Abdalla EE
Int J Health Sci (Qassim); 2010 Jan; 4(1):53-8. PubMed ID: 21475526
[TBL] [Abstract][Full Text] [Related]
3. Autonomic control of ventricular function in health and disease: current state of the art.
van Weperen VYH; Ripplinger CM; Vaseghi M
Clin Auton Res; 2023 Aug; 33(4):491-517. PubMed ID: 37166736
[TBL] [Abstract][Full Text] [Related]
4. Impairment of hormone-stimulated cardiac adenylate cyclase activity in the genetically obese (fa/fa) Zucker rat.
Chatelain P; Robberecht P; De Neef P; Camus JC; Poloczek P; Christophe J
Pflugers Arch; 1981 Apr; 390(1):10-6. PubMed ID: 6264381
[TBL] [Abstract][Full Text] [Related]
5. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
[TBL] [Abstract][Full Text] [Related]
6. The cardiac inotropic response to secretin is lower in genetically obese (fa/fa) than in lean (fa/?) Zucker rats.
Robberecht P; De Neef P; Camus JC; Waelbroeck M; Fontaine J; Christophe J
Pflugers Arch; 1983 Aug; 398(3):217-20. PubMed ID: 6314240
[TBL] [Abstract][Full Text] [Related]
7. Specific decrease of secretin/VIP-stimulated adenylate cyclase in the heart from the Lyon strain of hypertensive rats.
Robberecht P; Gillet L; Chatelain P; De Neef P; Camus JC; Vincent M; Sassard J; Christophe J
Peptides; 1984; 5(2):355-8. PubMed ID: 6473161
[TBL] [Abstract][Full Text] [Related]
8. Secretin and VIP-stimulated adenylate cyclase from rat heart. II. Impairment in spontaneous hypertension.
Chatelain P; Robberecht P; De Neef P; Camus JC; Heuse D; Christophe J
Pflugers Arch; 1980 Dec; 389(1):29-35. PubMed ID: 7193464
[TBL] [Abstract][Full Text] [Related]
9. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
Christophe J; Waelbroeck M; Chatelain P; Robberecht P
Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
[TBL] [Abstract][Full Text] [Related]
10. Secretin receptor activity in rat gastric glands. Binding studies, cAMP generation and pharmacology.
Gespach C; Bataille D; Vauclin N; Moroder L; Wünsch E; Rosselin G
Peptides; 1986; 7 Suppl 1():155-63. PubMed ID: 3018694
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide receptors in pancreas and liver. Structure-function relationship.
Christophe J; Svoboda M; Waelbroeck M; Winand J; Robberecht P
Ann N Y Acad Sci; 1988; 527():238-56. PubMed ID: 2839079
[TBL] [Abstract][Full Text] [Related]
12. Effector mechanisms of peptides of the VIP family.
Christophe J; Svoboda M; Lambert M; Waelbroeck M; Winand J; Dehaye JP; Vandermeers-Piret MC; Vandermeers A; Robberecht P
Peptides; 1986; 7 Suppl 1():101-7. PubMed ID: 3018687
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
